A Comparison of Trimethoprim-Sulfamethoxazole plus Nystatin with Gentamicin plus Nystatin in the Prevention of Infections in Acute Leukemia

New England Journal of Medicine

Volumn 304, Issue 18, 1981, Pages 1057-1062

  Wade, James C ^a   Schimpff, Stephen C ^a   Hargadon, Michael T ^a   Fortner, Clarence L ^a   Young, Viola Mae ^a   Wiernik, Peter H ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GENTAMICIN; NYSTATIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACUTE LEUKEMIA; ADVERSE DRUG REACTION; ANOREXIA; BACTERIAL INFECTION; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG COMPARISON; HUMAN; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MYCOSIS; NAUSEA; ORAL DRUG ADMINISTRATION; PREVENTION; PREVENTIVE MEDICINE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; THERAPY; VOMITING;

EID: 0019448601     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198104303041801     Document Type: Article

References (27)

1. Levine A.S., Schimpff S.C., Graw R.G. Jr., Young R.C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974; 11:141-202.
2. Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64:328-340.
3. Schimpff S.C., Young V.M., Greene W.H., Vermeulen G.D., Moody M.R., Wiernik P.H. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972; 77:707-714.
4. Schimpff S.C. Infection prevention during granulocytopenia. In: Remington JS, Swartz M, eds. Current clinical topics in infectious diseases. New York: McGraw-Hill, 1980: 85-106.
5. Idem. Infection prevention during profound granulocytopenia: new approaches to alimentary canal microbial suppression. Ann Intern Med. 1980; 93:358-361.
6. van de Waaij D., Berghuis J.M., Lekkerkerk J.E.C. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Camb). 1972; 70:605-610.
7. Sleijfer D.T., Mulder N.H., deVries-Hospers H.G., et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer. 1980; 16:859-869.
8. Wormser G.P., Keusch G.T. Trimethoprim-sulfamethoxazole in the United States. Ann Intern Med. 1979; 91:420-429.
9. Hughes W.T., Kuhn S., Chaudhary S., et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl I Med. 1977; 297:1419-1426.
10. Gurwith M.J., Brunton J.L., Lank B.A., Harding G.K.M., Ronald A.R. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med. 1979; 66:248-256.
11. Murillo J., Schimpff S.C., Brouillet M.D. Axillary lesions in patients with acute leukemia: evaluation of a preventive program. Cancer. 1979; 43:1493-1496.
12. Peterson D., Overholser D., Williams L., et al. Reduced periodontal infection in patients with acute nonlymphocytic leukemia following rigorous oral hygiene. Presented at a meeting of the American Society of Clinical Oncology, San Diego, May 27, 1980.
13. Remington J.S., Schimpff S.C. Please don#x0027;t eat the salads. N Engl J Med. 1981; 304:433-435.
14. Ewing M. Infections complicating the abnormal host. New York: Yorke, 1968.
15. Bauer A.W., Kirby W.M.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45:493-496.
16. MacLowry J.D., Jaqua M.J., Selepak S.T. Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing. Appl Microbiol. 1970; 20:46-53.
17. Yates J.W., Holland J.F. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973; 32:1490-1498.
18. Schimpff S.C., Greene W.H., Young V.M., et al. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975; 82:351-358.
19. Levine A.S., Siegel S.E., Schreiber A.D., et al. Protected environments and prophylactic antibiotics: a prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973; 288: 477-83.
20. Storring R.A., Jameson B., McElwain T.J., Wiltshaw E., Spiers A.S.D., Gaya H. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977; 2:837-840.
21. Levi J.A., Vincent P.C., Jennis F., Lind D.E., Gunz F.W. Prophylactic oral antibiotics in the management of acute leukaemia. Med J Aust. 1973; 1:1025-1029.
22. Rodriguez V., Bodey G.P., Freireich E.J., et al. Randomized trial of protected environment-prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore). 1978; 57:253-266.
23. Bodey G.P., Gehan E.A., Freireich E.J., Frei E. III. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci. 1971; 262:138-151.
24. Hahn D.M., Schimpff S.C., Fortner C.L., Smyth A.C., Young V.M., Wiernik P.H. Infection in acute leukemia patients receiving oral nonabsorbable antibiotics. Antimicrob Agents Chemother. 1978; 13:958-964.
25. Dietrich M., Gaus W., Vossen J., van der Waaij D., Wendt F. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection: a prospective cooperative study of gnotobiotic care in acute leukemia patients. I. Clinical results. Infection. 1977; 5:310.
26. Claas F.H. Jr., van der Meer J.W.M., Langerak J. Immunologic effect of co-trimoxazole on platelets. Br J Med. 1979; 2:898-899.
27. Deeg H.J., Meyers J.D., Storb R., Graham T.C., Weiden P.L. Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs. Transplantation. 1979; 28:243-246.